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To clarify the effects of dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS) on arteriolar 
biomechanics in a rat model and the possible modulatory role of vitamin D3. Methods and Results: The PCOS model 
was induced in female Wistar rats by ten-weeks DHT treatment. Arteriolar biomechanics was tested in arterioles by 
pressure arteriography in control as well as DHT- and DHT with vitamin D3-treated animals in contracted and 
passive conditions. Increased wall stress and distensibility as well as increased vascular lumen were detected after 
DHT treatment. Concomitant vitamin D3 treatment lowered the mechanical load of the arterioles and restored the 
vascular diameter. Conclusion: The hyperandrogenic state resulted in more rigid, less flexible arteriolar walls with 
increased vascular lumen compared with controls. DHT treatment caused eutrophic remodelling of gracilis arteriole. 
These prehypertensive alterations caused by chronic DHT treatment were mostly reversed by concomitant vitamin 
D3 administration.
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Polycystic ovary syndrome is a frequent cause of infertility and affects 5–8 percents of 
women. It is also well known that in PCOS, women of reproductive age may develop vascular 
damage. Ten years ago, Lakhani and Hardiman showed that the internal carotid artery 
pulsatility index was decreased and cardiovascular risk was increased in women with PCOS 
(3). The mechanisms behind this increased risk and the possible therapeutic approaches are 
still in the focus of research. Women with PCOS have a high prevalence of early-onset 
atherosclerosis, metabolic syndrome and insulin resistance, and they might develop 
hypertension during their reproductive period (2). These abnormalities are partly explained 
by biomechanical remodelling of resistance arteries. The aim of our study was to identify 
early mechanical alterations in a morphologically stable skeletal muscle vessel, the gracilis 
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arteriole, in a rat PCOS model. Manneras et al. have developed an adequate PCOS rodent 
model. Adolescent female rats that receive chronic dihydrotestosterone (DHT) treatment, 
develop a hyperandrogenic condition similar to human PCOS (6, 18).
In clinical practice, chronic treatment of PCOS might improve mechanical properties 
of arteries. The positive effect from insulin-sensitising therapy on the mechanical and 
pharmacological responsiveness of arteries has recently been shown (1, 8). Vitamin D3 may 
also be used as adjuvant therapy in women with PCOS (14). The positive effect of vitamin D3 
therapy on the prevention of general cardiovascular complications has been demonstrated (9, 
17). Herein, we investigated the effect of low-dose vitamin D3 treatment on the vascular 
biomechanical adaptation of gracilis arterioles in a rat PCOS model.
Methods and Materials
Chemicals
Pentobarbital (Nembutal, Phylaxia-Sanofi, Budapest, Hungary) was used for anesthesia. 
Following chronic surgical intervention, 20 mg amoxicillin and 4 mg clavulanic acid 
(Augmentin GlaxoSmithKline, Memphis, US) in 0.2 ml saline was administered 
intramuscularly to prevent infection. We followed the protocol to induce experimental 
polycystic ovary syndrome described by Manneras et al. (6). Continuous-release pellets that 
contained 7.5 mg dihydrotestosterone (DHT, Innovative Research of America, Sarasota, Fl, 
USA) were applied for 70 days. Eighty-three micrograms/day release for 90 days is guaranteed 
by the manufacturer. We purchased 1.25 (OH)2 D3 vitamin (Inj. Calcijex, 2 μg/ml) from 
Abbott Lab., Illinois, USA. The composition of the normal Krebs-Ringer solution used in 
these in vitro studies was as follows (in mmol/L): NaCl 119, KCl 4.7, NaH2PO4 1.2, MgSO4 
1.17, NaHCO3 24, CaCl2 2.5, glucose 5.5 and EDTA 0.034. The Ca2+-free Krebs solution that 
was used to relax the smooth muscle contained the following (in mmol/L): NaCl 92, KCl 4.7, 
NaH2PO4 1.18, MgCl2 20, MgSO4 1.17, NaHCO3 24, glucose 5.5, EGTA 2 and EDTA 0.025. 
The temperature of the solution was maintained at 37 °C, and it was bubbled with 5% CO2, 
20% O2, and 75% N2, which stabilized the pH at 7.4. Norepinephrine (NE), was obtained 
from Sigma-Aldrich Co. (St. Louis, MO, USA and Budapest, Hungary) and freshly prepared 
on the day of the experiment.
Animals
Thirty adolescent (21- to 28-day-old) female Wistar rats (provided by the Animal Facility at 
the Semmelweis University in agreement with Charles River Ltd.) that weighed 100–140 g 
when the study began were used. Twenty of the animals received subcutaneous pellets 
containing 7.5 mg DHT implanted under the back skin under anesthesia (Nembutal 45 mg/kg 
i.p.) in sterile conditions (DHT-treated female groups), which induces polycystic ovary 
syndrome (6). Ten animals underwent sham operations. During and after these procedures 
there were no surgical complications, no signs of distress or suffering. 
Ten DHT-treated animals received 120 ng/100 g body weight/ week 1.25 (OH)2 D3 
vitamin (DHT+D3 group) subcutaneously as previously described by Przybilski et al. We 
applied a weekly dosage instead of a daily administration (9) to reduce stress on the animals. 
A vehicle was given to the remaining 20 animals. No medical or surgical complications were 
observed. Conventional rat food and tap water were provided ad libitum. After eight weeks 
of DHT treatment a significantly higher 120-minute postload insulin level were measured in 
DHT group than in the controls, and this difference was eliminated by the D3 vitamin treatment 
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(10). There was not any difference in glucose levels (10). The investigation conforms to the 
Principles of Laboratory Animal Care NIH publication No. 85-23, revised 1985) as well as 
the Euroconform Hungarian Law on Animal Care (XXVIII/1998), and the study protocol 
was accepted by the institutional Animal Care Commission (IRB approval: 22.1/2960/ 
003/2009).
Biomechanics of a musculocutaneous arteriole (pressure arteriography)
The animals’ blood pressure was measured directly by cannulation of the carotid artery in 
general surgical anesthesia. Nembutal was given i.p., 50 mg/kg, 1/3rd of the dose repeated if 
repeated checks of pain and corneal reflexes made it desirable. Then the animals were bled 
under anesthesia, adductor muscle group and ovaries were removed from the cadavers. After 
opening the iliofemoral region, the arteriole, which had an in vivo diameter of approximately 
200 μm and is the blood supply for the gracilis muscle, was removed and placed into a vessel 
chamber filled with normal Krebs-Ringer (nKR) solution. It was cannulated at both ends with 
plastic microcannulas and extended to its in vivo length. Both cannulas were connected to 
pressure-servo pumps (Living Systems, Burlington, VT), and the arterioles were pressurised 
under a no-flow condition to 50 mmHg intraluminal pressure.
The outer and the inner diameters of the arterioles were measured by video-microscopic 
pressure microangiometry. In this setup, the glass-bottomed tissue bath was positioned in the 
light path of an inversed Leica microscope. A magnified picture of the vessel was formed 
with the aid of a video camera (Leica DFC320) and Leica QWin software. The digitalized 
pictures were saved, and off-line measurements of the inner and outer diameter were made 
using Leica QWin image analysis software.
The gracilis arterioles were allowed to equilibrate for 30 minutes at 50 mmHg 
intraluminal pressure in an oxygenised nKR solution. Following incubation, the pressure was 
decreased to 10 mmHg and then increased to 100 mmHg in 10-mmHg pressure steps. The 
steady state diameter at each step was measured. During NE contraction (after 10-minute 
incubation with 10–6 M NE) the pressure-diameter curve was repeated as described above. 
After recording the NE-curve, the passive diameter was measured in Ca2+-free Krebs solution. 
Arteriolar segments were incubated for 20 minutes, and the steady-state, fully relaxed 
diameter was then measured as described above. We used a micrometer etalon (Wild) for the 
calibrations.
Biomechanical calculations
From the originally calibrated pressure-diameter plots, the following geometrical and 
biomechanical parameters were computed for each intraluminal pressure level (16). Tangential 
stress was computed according to the Laplace equation: σtang = P × ri /h, where σtang is the 
tangential (circumferential) wall stress, p is the intraluminal pressure, ri is the inner radius 
and h is the wall thickness (h = ro–ri,, where ro is the outer radius). Incremental distensibility 
was computed as Dinc = ΔV/V × ΔP where Dinc is the incremental distensibility and ΔV is the 
change in vessel lumen volume in relation to the initial volume V in response to the pressure 
change ΔP. The circumferential incremental elastic modulus was computed from the following 
equation: Einc = (ΔP/Δro) × 2ri2 × ro/(ro2–ri2), where Einc is the incremental elastic modulus, ri is 
the inner radius, ro is the outer radius, and Δro is the change in outer radius in response to 
intraluminal pressure change of ΔP.
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Histology
The ovaries and arterioles were formaldehyde fixed, stained with hematoxylin-eosine and 
histologically examined by using the Pannoramic Viewer software. We detected a polycystic 
morphology in the DHT-treated groups and normal ovaries in the controls, as published 
earlier by Manneras and Yanes (6, 10, 18).
Statistical analysis
For statistical analysis, repeated-measures ANOVA was used. In vitro parameters were 
plotted as a function of intraluminal pressure, and the curves were analysed by paired 
comparisons of the treatment groups. One-way ANOVA was applied for the discrete 
parameters (e.g., blood pressure). As post hoc test, Tukey`s test was used. p < 0.05 was 
uniformly accepted as a significant difference. Data are presented as mean ± SEM. GraphPad 
Prism version 5.0d was used as statistical software.
Results
Physiological parameters
The mean arterial pressure was 122 ± 3 mmHg, 123 ± 6 mmHg and 123 ± 4 mmHg for the 
controls, the DHT-group and the DHT+vitamin D3-treated group, respectively (non-
significant). The body weights at the end of the experiment were 298 ± 8 g, 354 ± 16 g and 
353 ± 9 g for the same groups, respectively. The DHT-treated animals had significantly higher 
body weights than the controls (p < 0.01), but there was no difference between the two DHT-
treated groups.
Arteriole geometry
DHT treatment increased the relaxed outer (Fig.1) radii (measured in a Ca2+-free medium), 
which were diminished by a parallel vitamin D3 treatment (p < 0.05 for DHT vs. DHT+D3 
comparison, Fig. 1). The wall thicknesses for the different groups in the Ca2+-free medium 
were as follows: 20 ± 2 μm, 19 ± 1 μm and 20 ± 1 μm in the control, DHT- and DHT + 
vitamin D3-treated groups, respectively (as measured at 50 mmHg, non-significant). In Ca2+-
free solution, the cross section areas for the vessel walls were 12080 ± 1627 μm2, 12542 ± 
1090 μm2 and 11348 ± 660 μm2 for these groups, which were not significant.
Arteriole elasticity
The mechanical load on the vessel wall was measured, and the tangential wall stress was 
significantly higher throughout the entire pressure range for the DHT-treated group compared 
with the other two groups in both Ca2+-free solution and during NE contraction (Fig. 2a, b, p 
< 0.05). Vitamin D3 treatment induced a partial reversal in the NE-contracted segments and 
an overcompensation in the Ca2+-free solution (Fig. 2, both for DHT vs. DHT + D3 and the 
control vs. DHT + D3, p < 0.05).
Isobaric distensibility was significantly higher throughout the entire pressure range for 
the DHT group compared with the other two groups in both the Ca2+-free medium and during 
norepinephrine contraction (Fig. 3a, b, p < 0.05). In response to a parallel treatment with 
vitamin D3, relaxed distensibility fully returned to the control value (Fig. 3a), while NE 
contraction only generated a partial recovery (Fig. 3b).
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Fig. 1. Outer radii (Ro) in a Ca2+-free solution.
The outer radii from Ca2+-free relaxation at P = 50 mmHg were not different in the controls and DHT+D3. Both 
radii were smaller than in the arterioles isolated from the DHT-treated animals (p < 0.05). The values are expressed 
as the mean ± SEM. *DHT was significantly different from the control. ‡ The DHT+D3 was significantly different 
from the DHT group
Fig. 2a. Tangential wall stress in the Ca2+-free solution. 
The tangential wall stress was significantly greater in the DHT group than in the other two groups throughout the 
entire pressure range, (p < 0.001). Between 70–100 mmHg, the stress was significantly lower in the DHT+D3 
group (p < 0.001).
Fig. 2b. NE-induced tangential stress. Tangential wall stress was significantly greater in the DHT group than in the 
other two groups throughout the entire pressure range, (p < 0.001).
Values are expressed as the mean ± SEM. * DHT was significantly different from the control. † DHT+D3 was 
significantly different from the control. ‡ The DHT+D3 group was significantly different from the DHT group
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Fig. 3a. Distensibility in a Ca2+-free solution. Distensibility was significantly greater in the DHT group compared 
with the other two groups throughout the entire pressure range (10–100 mmHg), (p < 0.0001).
Fig. 3b. NE induced distensibility. Each group was significantly different throughout the entire pressure range  
(p < 0.0001). Distensibility was greatest in the DHT animals and lowest in the control animals.
Values are expressed as the mean ± SEM. * DHT was significantly different from the control. † DHT+D3 was 
significantly different from the control. ‡ The DHT+D3 group was significantly different from the DHT group
Fig. 4. Elastic moduli as a function of tangential wall stress in the Ca2+-free solution. The values for the abscissa 
show the elastic moduli (logkPa) for the arterioles from the control rats as well as the DHT- and DHT+D3-treated 
rats. The ordinata shows the tangential stress (kPa). There were no significant differences between the groups. The 
values are expressed as the mean ± SEM
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Wall elastic moduli were not affected by DHT and vitamin D3 treatment (in a Ca2+-free 
solution, the log elastic moduli were 2.8 ± 0.14 log(kPa), 2.7 ± 0.16 log(kPa) and 2.4 ± 0.11 
log(kPa) in the control, DHT- and DHT + vitamin D3-treated groups, respectively, ns.). There 
was no difference in the elastic moduli as a function of tangential wall stress (Fig. 4, ns.). 
Discussion
Chronic DHT treatment of female rats, which is an animal model for human PCOS, induced 
significant alterations in the biomechanical properties of a skeletal muscle arteriole. The 
relaxed lumen was dilated but this was not accompanied by an elevation in wall mass 
(eutrophic remodelling). This elevated wall stress was accompanied by an increase in isobaric 
distensibility. The elastic moduli did not change, which demonstrates that passive elastic 
element remodelling was limited.
Vitamin D3 is an adjuvant therapy for PCOS (14), and the cardiovascular protective 
effect of low-dose vitamin D3 therapy is widely accepted (9, 17, 19). Our experiments 
demonstrate that Vitamin D3 can reverse morphological remodelling, elevation of wall stress 
and distensibility in a resistance vessel.
This is the first study to explore the details of vascular biomechanical adaptation of a 
resistance artery in an experimental PCOS model. We are the first to show that these changes 
are partially counteracted by vitamin D3, which is as adjuvant treatment often applied for 
PCOS.
Our results show basic changes in vascular biomechanics in response to DHT treatment; 
the arteriolar walls become more rigid with increased tangential wall stress compared with 
the controls. Thus, the mechanical load of the vessels increases. Under passive circumstances, 
vitamin D3 treatment fully restores the biomechanical balance of the vessel wall. However, in 
response to norepinephrine, mechanical load of the vessel wall increases compared with the 
control group, although it does not reach the level of the DHT-treated group.
In our study, we used an experimental PCOS model described by Manneras. The DHT 
treatment scheme used herein has proved to be an adequate rat PCOS model (6).
It has been shown that an 8- to 12-week DHT treatment – identical to the treatment that 
we used – induces polycystic ovary syndrome and significantly (3-fold) increases androgen 
levels in female rats (6). Yanes detected several metabolic abnormalities (18). During a 90-
day treatment, she detected an increase in the rat spontaneous proteinuria; morphological 
renal damage; elevated TGF alpha; leptin and cholesterol levels. These metabolic 
abnormalities might also influence arterial mechanics; distensibility and stiffness. Despite the 
normal estradiol level, DHT-treated animals exhibited oestrus cycle dysfunction (6, 18). A 
significant increase in body weight was detected, which was also noted in herein. This effect 
was not influenced by vitamin D3 treatment.
The DHT treatment applied by Yanes et al. caused hypertension when it was administered 
for a longer period of time (90 days). During our 70-day treatment, no significant differences 
were found between the blood pressure values of the experimental groups. However, the 
tangential wall stress and distensibility differences that were detected even in normotensive 
animals might be considered prehypertensive abnormalities. The enhanced mechanical load 
of the arteriolar wall is the local factor for the self-perpetuating, vicious cycle of emerging 
hypertension. In the vitamin D-treated group, tangential wall stress is not elevated – this 
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might be a local effect against development of hypertension. This effect of vitamin D might 
be explained by enhanced proliferation of elastin components as it was demonstrated in aortic 
smooth muscle cells in vitro (15).
Because the blood pressures for the different animal groups did not differ in our 
study, the vascular biomechanical changes detected are directly attributable to either a 
hyperandrogenic state or induced hyperinsulinemia/insulin resistance. As we reported 
previously, insulin resistance was developed after eight weeks of DHT treatment (10). It is 
well known that vascular biomechanical functions are worse in PCOS. In 2000, Lakhani 
suggested that internal carotid artery pulsatility index was decreased, and cardiovascular risk 
is increased in women with PCOS (3). Lakhani then showed an increased intima-media 
thickness for the common carotid and femoral arteries in young (under the age of 35) women 
with PCOS (4). It is known that in PCOS, large arteries become less elastic and more rigid; 
the stiffness and intima-media thickness of the common carotid artery increases, and its 
distensibility decreases (2, 5, 12). These changes correlate with a hyperandrogenic state 
rather than obesity (5). Calcification of the coronary arteries is enhanced (2), and a higher 
brachial-ankle pulse wave velocity is detected (11); thus, the vicious cycle of atherosclerosis 
also begins at an earlier age. Therefore, the early development of atherosclerosis and increased 
cardiovascular risk can be regarded as consequences of the hyperandrogenic state (2, 11). 
According to Soares, the early increase of cardiovascular risk, which is independent of other 
risk factors, is a part of polycystic ovary syndrome (12). Meyer has suggested that in addition 
to hyperandrogenic symptoms, changes in glucose metabolism and arterial stiffness (pulse 
wave velocity) should also be considered in treating PCOS. Meyer suggested treatment with 
metformin instead of high-dose oral contraceptives (7). Agarwal has shown that metformin 
decreases arterial stiffness, aortic and brachial pulse wave velocity, and aortic augmentation 
index (1). In PCOS, vascular biomechanical damage is essential and progresses faster than in 
the general population (2). The treatment modalities used in PCOS often modify this risk (1, 
7). High-dose oral contraceptives might increase cardiovascular risk; metformin has been 
shown to decrease this risk, whereas low-dose oral contraceptives likely have no significant 
effect (1, 7). Herein, we provide these first data for the effect of vitamin D3 on the mechanical 
properties of arteries in PCOS. Vitamin D3 can be administered as an adjuvant therapy for 
PCOS (14), and the cardiovascular protective effect of low-dose vitamin D3 therapy is widely 
known (9, 17, 19). The results from our study show that for PCOS, vitamin D is an adjuvant 
treatment that might inhibit arterial vascular mechanical impairment and potentiate the 
vascular protective effect of metformin because of its distinct mechanism.
Chronic vitamin D3 treatment directly decreased blood pressure and the vasoconstrictor 
response in isolated arteries from SHR rats. The latter effect was attributed to reduced COX-
1 expression, while intracellular Ca-levels remained unchanged (17). Other direct effects of 
vitamin D on vasodilation were also suspected which are independent from Ca metabolism 
(13). Vitamin D3 treatment mostly prevented arteriolar morphological remodelling and the 
increase in lumen volume caused by DHT treatment.
Conclusions
This is the first study to investigate the details of the vascular biomechanical adaptation of 
skeletal muscle arterioles in a PCOS model. Our results show that the hyperandrogenic state 
led to more rigid, less flexible arteriolar walls. In the relaxed vessels, vitamin D3 treatment 
corrected wall distensibility and mechanics to the control level. However, NE contraction 
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resulted in slightly less flexible vessels (Figs 2, 3). In conclusion, pathological prehypertensive 
biomechanical adaptation of arterioles was found in this PCOS model that was mostly 
prevented by concomitant vitamin D3 administration.
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